Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RARE

Ultragenyx Pharmaceutical Inc.

CIK 0001515673 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$34.61
↓ 0.06 (-0.17%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Options

Key stats

Market Cap
$3.41B
P/E Ratio
-5.60
EPS
-5.83
Dividend Yield
Not covered
52W Position
68%
Beta
1.26

Valuation multiples

Fwd P/E
Not covered
PEG
-0.24
P/B
-14.44
P/S
5.09
EV/Revenue
4.83
ROE
258.0%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 68%
$18.29$42.37

Latest Financials

2025-12-31 FY
Revenue
$673.00M
Net Income
-$575.00M
Total Assets
$1.53B
Free Cash Flow
-$472.00M

Recent news